Cargando…
Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii
Toxoplasma gondii is a protozoan that infects up to a third of the world’s population. This parasite can cause serious problems, especially if a woman is infected during pregnancy, when toxoplasmosis can cause miscarriage, or serious complications to the baby, or in an immunocompromised person, when...
Autores principales: | Cajazeiro, Débora Chaves, Toledo, Paula Pereira Marques, de Sousa, Natália Ferreira, Scotti, Marcus Tullius, Reimão, Juliana Quero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414507/ https://www.ncbi.nlm.nih.gov/pubmed/36015260 http://dx.doi.org/10.3390/pharmaceutics14081634 |
Ejemplares similares
-
Repurposing the Medicines for Malaria Venture’s COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice
por: dos Santos, Bruna Ramos, et al.
Publicado: (2023) -
Systematic identification of the lysine lactylation in the protozoan parasite Toxoplasma gondii
por: Zhao, Wei, et al.
Publicado: (2022) -
Phagocyte Responses to Protozoan Infection and How Toxoplasma gondii Meets the Challenge
por: Denkers, Eric Y., et al.
Publicado: (2012) -
MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondii
por: Kelsen, Anne, et al.
Publicado: (2023) -
Transcriptional regulation of two stage-specifically expressed genes in the protozoan parasite Toxoplasma gondii
por: Kibe, Michael K., et al.
Publicado: (2005)